Alitter Qusai T, Jarrar Ahmad, AlSoud Fahed, Gadelmoula Islam
Division of Cardiology, Interdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, Miami, USA.
Department of Pulmonary Medicine, Larkin Community Hospital, Hialeah, USA.
Cureus. 2023 Jan 31;15(1):e34464. doi: 10.7759/cureus.34464. eCollection 2023 Jan.
Coronavirus disease 2019 (COVID-19) has been primarily linked to respiratory complications, including acute respiratory distress syndrome (ARDS). However, several systemic manifestations of the disease may also occur. One of the emerging complications that is being increasingly reported in the literature is the hypercoagulable and intense inflammatory state in COVID-19 patients, which leads to venous and/or arterial thrombosis, vasospasm, and ischemia. Despite the recent advances in diagnostic and treatment modalities, the diagnosis and management of vascular ischemia in this patient population remain a challenge, resulting in increased morbidity and mortality. In this case report, we highlight the etiology and potential treatment of limb ischemia in COVID-19 patients.
2019冠状病毒病（COVID-19）主要与包括急性呼吸窘迫综合征（ARDS）在内的呼吸道并发症相关。然而，该疾病也可能出现一些全身表现。文献中越来越多地报道的一种新出现的并发症是COVID-19患者的高凝和强烈炎症状态，这会导致静脉和/或动脉血栓形成、血管痉挛和缺血。尽管在诊断和治疗方式方面取得了最新进展，但对这一患者群体的血管缺血的诊断和管理仍然是一项挑战，导致发病率和死亡率增加。在本病例报告中，我们重点介绍了COVID-19患者肢体缺血的病因和潜在治疗方法。
